论文部分内容阅读
自国内报道用人胎肝细胞悬液(FLC)治疗慢性肝炎获得较好疗效以来,越来越多引起临床医生的关注。我们于1989年9月至1990年6月用空军广州医院从乳猪肝细胞提制的肝细胞生长素(hepatocyte erowth factot,HGF)治疗慢性活动性乙型肝炎(CHA)和肝炎后肝硬化21例,并以同样病例10例作为对照组,现将治疗结果报告如下。材料和方法病例选择:随机选31例住院慢性肝炎患者。按1984年南宁全国肝炎会议制订的方案统一诊断标准。治疗组(a组)21例,CAH11例(4例肝穿证实);肝炎后肝硬能10例。年
Since the domestic reports of human fetal liver cell suspension (FLC) treatment of chronic hepatitis to obtain better efficacy, more and more attracted the attention of clinicians. From September 1989 to June 1990, we used hepatocyte erowth factot (HGF) extracted from suckling pig liver cells at Guangzhou Guangzhou Hospital to treat chronic active hepatitis B (CHA) and posthepatitis cirrhosis 21 Cases, and the same case of 10 cases as a control group, the treatment results are reported as follows. Materials and Methods Case Selection: 31 patients were randomly selected hospitalized patients with chronic hepatitis. According to the 1984 Nanning National Hepatitis Conference program to develop a unified diagnostic criteria. The treatment group (group a) 21 cases, CAH 11 cases (4 cases of liver wear confirmed); hepatitis cirrhosis 10 cases. year